Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HELPER: H. pylori Eradication for Gastric Cancer Prevention
NCT02112214Phase 3Active, not recruiting
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Jun 2014
- Primary completion
- Dec 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bismuth subsalicylate, lansoprazole, metronidazole, tetracycline in gastric cancer (GC), sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Started Jun 2014; status: active, not recruiting.
02
Drugs
bismuth subsalicylatelansoprazolemetronidazoletetracycline
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT02112214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02112214.